In June of 2021, the GOP-controlled Pennsylvania Senate blocked an amendment to a House-passed medical marijuana bill that would have allowed registered patients to grow their own plants for personal use.
Under the proposal from Sen. Sharif Street (D), patients 21 and older would have been able to cultivate up to five plants. That would’ve marked a notable expansion of the state’s existing program through which cannabis is only legally available from dispensaries. Members tabled the amendment in a party-line vote of 29-21. The full medical marijuana legislation it would have been attached to later advanced without the homegrow provision in a 47-3 vote.
Prior to this homegrow amendment being blocked, Scott Paterno, a registered lobbyist with Jushi, tweeted against homegrow rights.
Jushi's brands in Pennsylvania include Beyond Hello, The Lab, The Bank, and Nira.
Vireo Health, PharmaCann, and Columbia Care opposed homegrow in 2019 through their organization, NYMCIA, claiming home cultivation “creates a significant public safety and black market risk.”
Vireo markets their Vireo brand in Pennsylvania. PharmaCann brands in Pennsylvania include Verilife and Matter. Columbia Care owns dispensaries in Pennsylvania.